Literature DB >> 22675796

Fish oil supplementation & coronary artery disease: does it help?

Subrata Kar1, Richard Webel.   

Abstract

Omega-3 polyunsaturated fatty acids (PUFAs) have been shown to decrease the risk of cardiovascular disease. They reduce fatal and non-fatal myocardial infarction, stroke, coronary artery disease (CAD), sudden cardiac death, and all-cause mortality. They are well tolerated and cause minimal adverse effects. In this review, we sought to provide an overview of the current literature on the use of Omega-3 fatty acids for the treatment of CAD and discuss the possible benefits.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22675796      PMCID： PMC6181727     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  26 in total

1.  On the reanalysis of the GISSI-Prevenzione.

Authors:  Alexander Leaf
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

2.  n-3 fatty acids and cardiovascular events after myocardial infarction.

Authors:  Daan Kromhout; Erik J Giltay; Johanna M Geleijnse
Journal:  N Engl J Med       Date:  2010-08-28       Impact factor: 91.245

3.  Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2005-11-07       Impact factor: 1.909

Review 4.  Dietary omega-3 fatty acid intake and cardiovascular risk.

Authors:  Tricia L Psota; Sarah K Gebauer; Penny Kris-Etherton
Journal:  Am J Cardiol       Date:  2006-05-30       Impact factor: 2.778

Review 5.  Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.

Authors:  Jennifer G Robinson; Neil J Stone
Journal:  Am J Cardiol       Date:  2006-05-30       Impact factor: 2.778

Review 6.  Combination therapy with statins and omega-3 fatty acids.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  Am J Cardiol       Date:  2006-05-30       Impact factor: 2.778

7.  The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.

Authors:  A F Stalenhoef; J de Graaf; M E Wittekoek; S J Bredie; P N Demacker; J J Kastelein
Journal:  Atherosclerosis       Date:  2000-11       Impact factor: 5.162

Review 8.  Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations.

Authors:  Subrata Kar; Anand Chockalingam
Journal:  Am J Ther       Date:  2013-01       Impact factor: 2.688

9.  OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.

Authors:  Bernhard Rauch; Rudolf Schiele; Steffen Schneider; Frank Diller; Norbert Victor; Helmut Gohlke; Martin Gottwik; Gerhard Steinbeck; Ulrike Del Castillo; Rudolf Sack; Heinrich Worth; Hugo Katus; Wilhelm Spitzer; Georg Sabin; Jochen Senges
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

Review 10.  Nutritional supplements and serum lipids: does anything work?

Authors:  Mary P McGowan; Suzanne Proulx
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113
View more
  7 in total

1.  Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease.

Authors:  Magdalena Mostowik; Grzegorz Gajos; Jaroslaw Zalewski; Jadwiga Nessler; Anetta Undas
Journal:  Cardiovasc Drugs Ther       Date:  2013-08       Impact factor: 3.727

Review 2.  Omega-3 polyunsaturated Fatty acids as potential chemopreventive agent for gastrointestinal cancer.

Authors:  Jong-Min Park; Sung-Hun Kwon; Young-Min Han; Ki-Baik Hahm; Eun-Hee Kim
Journal:  J Cancer Prev       Date:  2013-09

3.  Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats.

Authors:  Atef M Al-Attar; Hayfa A Al-Rethea
Journal:  Saudi J Biol Sci       Date:  2016-01-21       Impact factor: 4.219

Review 4.  Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.

Authors:  Nicolò Merendino; Lara Costantini; Laura Manzi; Romina Molinari; Donatella D'Eliseo; Francesca Velotti
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

Review 5.  Effect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in Cancer.

Authors:  Laura Manzi; Lara Costantini; Romina Molinari; Nicolò Merendino
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 6.  Omega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary Approach.

Authors:  Jong-Min Park; Migyeong Jeong; Eun-Hee Kim; Young-Min Han; Sung Hun Kwon; Ki-Baik Hahm
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 7.  Sleep Apnea and Inflammation - Getting a Good Night's Sleep with Omega-3 Supplementation.

Authors:  Fulvio A Scorza; Esper A Cavalheiro; Carla A Scorza; José C F Galduróz; Sergio Tufik; Monica L Andersen
Journal:  Front Neurol       Date:  2013-12-03       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.